IPOX® Associate Lukas Muehlbauer was quoted by Reuters on Parabilis Medicines’ upsized U.S. IPO, which targets a valuation of nearly $2.3 billion as biotech listings regain momentum. Muehlbauer said the larger offering signals a healthier biotech IPO pipeline, while noting investors remain selective and favor larger, better-backed deals. He also highlighted Parabilis’ Regeneron partnership as an external validation of the company’s technology and a source of added credibility ahead of its expected Nasdaq debut under ticker PBLS.

IPOX® CEO Josef Schuster was featured in Reuters’ View article on OpenAI’s confidential U.S. IPO filing, which examined how major AI companies are moving toward public markets. Schuster commented that SpaceX, OpenAI, and Anthropic are seeking public-market capital to finance significant growth, while noting that investors may both reward and punish these companies as their fundamentals develop. He also highlighted that their offering size and initial float could make post-listing trading highly dynamic over time for investors and markets alike.

IPOX® CEO Josef Schuster featured in Japan's largest business paper Nikkei on SpaceX’s planned mega IPO and its potential market impact. The article examines whether an offering of unprecedented scale could temporarily absorb capital, increase stock-specific volatility, and affect index rebalancing, while also attracting new investment over the longer term. Schuster noted that large IPOs can heighten individual-stock volatility and potentially ripple across broader markets, but that investors have limited precedent for an equity debut of this magnitude so far.

IPOX® Research Associate Lukas Muehlbauer commented on Innio’s Nasdaq debut in Reuters coverage of the gas engine maker’s upsized $2.43 billion IPO. Muehlbauer said the market backdrop is supportive for companies building the physical backbone of AI, as investors reward businesses tied to data-center power demand. He noted Innio’s established GE heritage and said the company must show equipment order growth can continue and translate into long-term service revenue for data centers requiring reliable power and maintenance over time globally.

IPOX® VP Kat Liu commented on Quantinuum’s Nasdaq debut in Reuters coverage of the Honeywell-backed quantum computing company’s upsized IPO. Liu said the investment case centers on quantum computing’s long-term role in future infrastructure, supported by its strategic relevance to national security, AI, communications and advanced computing. She also noted Quantinuum’s Honeywell backing and expansion into software, cybersecurity and quantum networking, while cautioning that commercial adoption remains limited and investors remain focused on the sector’s long-term opportunity.